Greenwich looks like a rocket ready to go off. All of the sideways action and accumulation combined with this bold move today makes a breakout very likely. I believe the company has fundamental potential as well. Good Luck!
Here, we have a cypher harmonic which will likely test lower prices past the normal prz swiftly with how volatile GSLI can be. A quick wick below the prz is to be expected. Good luck and trade safely!
1) $GLSI had 100% success preventing breast cancer recurrence over the last 6 years in their clinical trial 1 & trial 2. 2) Management team has 35+ years working together on several other successful biotech startups. They’re just repeating a proven biotech business model. 3) Executive team already multi-millionaires from previous successful ventures, they have...
Fundamental Analysis: Greenwich LifeSciences Inc. is a clinical-stage biopharmaceutical company that focuses on the development of a breast cancer immunotherapy treatment to prevent the recurrence of cancer following surgery. This treatment, GP2 , has been undergoing phase two clinical trials for a while, and the data from these trials will be released April...
Seems to be ready for a run. Consolidating for a long time after a huge jump on their breast-cancer news from 5 to 158 in a single day. Increase of the social sentiments around this ticker. I would perhaps get an initial swing position on Monday for longer-term play and add the dips. Risk/reward is very promising: SL at 33 and PT 45, 50, 52, and maybe even filling...
Hello fellow traders and all of you beautiful people that read my analyses. If you follow the markets you know that GLSI rallied over 2,900% in one single day on hopes of a new phase of their breast cancer treatment (bit.ly). If you were in it, I have to congratulate you. That is almost 30X your money in a single day! I truly hope you took some profits because...